Clinical trial • Phase III • Oncology
Clinical trial in Advanced solid tumors
Phase III trial for Advanced solid tumors. 95 participants.
Overview
- Trial Therapeutic Area
- Oncology
- Trial Disease
- Advanced solid tumors
- Trial Stage
- Phase III
Key dates
- Initial CTIS Submission Date
- 13-06-2024
- First CTIS Authorization Date
- 10-09-2024
Trial design
Phase III trial across 7 sites in Spain.
- Target Sample Size
- 95
Recruitment
- Planned Sample Size
- 95
- Recruitment Window Months
- 28
Geography
- Total Number Of Sites
- 7
- Total Number Of Participants
- 95
Spain
- Earliest CTIS Part Ii Submission Date
- 31-07-2024
- Latest Decision Or Authorization Date
- 28-08-2025
- Processing Time Days
- 393
- Number Of Sites
- 7
- Number Of Participants
- 50
Sites
- Site Name
- Hospital Universitario 12 De Octubre
- Department Name
- Oncology
- Contact Person Name
- David Olmos Hidalgo
- Contact Person Email
- dolmos.imas12@h12o.es
- Site Name
- Hospital Universitario Quironsalud Madrid
- Department Name
- Unidad de Ensayos Clínicos Fases I
- Contact Person Name
- Valentina Boni
- Contact Person Email
- vboni@nextoncology.eu
- Site Name
- Hospital Universitario Fundacion Jimenez Diaz
- Department Name
- Oncology
- Contact Person Name
- Bernard Gaston Doger de Speville Uribe
- Contact Person Email
- bernard.doger@startmadrid.com
- Site Name
- Hospital Universitari Vall D Hebron
- Department Name
- Oncology
- Contact Person Name
- Elena Garralda Cabanas
- Contact Person Email
- egarralda@vhio.net
- Site Name
- Institut Catala D'oncologia
- Department Name
- Oncology
- Contact Person Name
- Marta Gil Martin
- Contact Person Email
- mgilmartin@iconcologia.net
- Site Name
- Hospital Hm Nou Delfos
- Department Name
- Oncology
- Contact Person Name
- Tatiana Hernández Guerrero
- Contact Person Email
- tatiana.hernandez@start-barcelona.com
- Site Name
- Hospital Universitario Hm Sanchinarro
- Department Name
- Oncology
- Contact Person Name
- Irene Moreno Candilejo
- Contact Person Email
- irene.moreno@startmadrid.com
Sponsor
Primary sponsor
- Full Name
- Merck Healthcare KGaA
- Organisation Type
- Pharmaceutical company
- Country Of Registered Address
- Germany
Related trials
Other published trials that may interest you.